| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
1G T-Type Calcium Channels
From the Institut de Génomique Fonctionnelle (M.E.M., A.T., B.C., L.M., E.K., A.C.-S., J.N., P.L.), CNRS UMR5203-INSERM U661-Université de Montpellier IUniversité de Montpellier II, Département de Physiologie, Montpellier; Institut du Thorax (A.-L.L., K.L.Q., D.E., F.C.), INSERM U533, Faculté de Médecine, Nantes; Cardiovascular Research Center (J.V.), INSERM U689, Université Paris 7-Denis Diderot, Paris, France; and Center for Calcium and Learning (H.-S.S.), Korea Institute of Science and Technology, Cheongryang, Seoul, Republic of Korea.
Correspondence to Dr Matteo Mangoni, Institut de Génomique Fonctionnelle, CNRS UMR5203-INSERM U661, Université de Montpellier IUniversité de Montpellier II, Département de Physiologie, 141, rue de la Cardonille, Montpellier cedex 05, F-34094 France. E-mail matteo.mangoni{at}igf.cnrs.fr
| Abstract |
|---|
|
|
|---|
1G T-type calcium channels (cacna1g) abolishes T-type calcium current (ICa,T) in isolated cells from the SAN and the atrioventricular node without affecting the L-type Ca2+ current (ICa,L). By using telemetric electrocardiograms on unrestrained mice and intracardiac recordings, we find that cacna1g inactivation causes bradycardia and delays atrioventricular conduction without affecting the excitability of the right atrium. Consistently, no ICa,T was detected in right atrium myocytes in both wild-type and Cav3.1/ mice. Furthermore, inactivation of cacna1g significantly slowed the intrinsic in vivo heart rate, prolonged the SAN recovery time, and slowed pacemaker activity of individual SAN cells through a reduction of the slope of the diastolic depolarization. Our results demonstrate that Cav3.1/T-type Ca2+ channels contribute to SAN pacemaker activity and atrioventricular conduction.
Key Words: pacemaker activity T-type calcium channel sinoatrial node conduction knockout mice
| Introduction |
|---|
|
|
|---|
ICa,T has also been proposed to contribute to pacemaking in primary SAN20 as well as in latent pacemaker cells of the right atrium (RA).21 ICa,T is expressed in pacemaker cells of mammals, including the rabbit20 and the mouse.22 ICa,T is also expressed in the cardiac conduction system, the rabbit AVN,18 and in canine Purkinje cells.23,24 The functional role of ICa,T in the cardiac primary pacemaker and conduction tissue remains to be elucidated.
Molecular cloning of 3 T-type Ca2+ channel pore-forming subunits, namely the CaV3.1/
1G, CaV3.2/
1H, and CaV3.3/
1I subunits, has fostered investigation of the role of native ICa,T.25 Here, we describe that CaV3.1 knockout (CaV3.1/) mice lack ICa,T in both SAN pacemaker and AVN cells and display slowed pacemaker activity and AV conduction. Our results constitute the first direct functional demonstration of the participation of Cav3.1 channels in pacemaking and cardiac conduction.
| Materials and Methods |
|---|
|
|
|---|
| Results |
|---|
|
|
|---|
|
To determine whether the pharmacological sensitivity of the SAN ICa,T is consistent with the expression of the Cav3.1 subunit, we tested its sensitivity to Ni2+ ions (Figure 2A and 2B). Application of Ni2+ concentrations of 50 and 200 µmol/L inhibited 26±9% (N=2, n=4) and 61±10% (n=9) of ICa,T, respectively. Because the IC50 values for Ni2+ on recombinant CaV3.1 and CaV3.2 T-type channels are in the range of 100 to 200 µmol/L and 5 to 10 µmol/L, respectively,27 these results indicate that ICa,T in mouse adult SAN cells is generated by the CaV3.1 subunit. Consistent with these findings, real-time RT-PCR experiments showed that the Cav3.1 subunit is the predominant T-type Ca2+ channel isotype in the SAN of the adult mouse (supplemental Figure II). Furthermore, application of 2 µmol/L of the 1,4-dihydropyridine ICa,L blocker isradipine on Cav3.1/ SAN cells blocked ICa by 93±4% (N=5, n=7, Figure 2C and 2E) from a HP of 90 mV and by 100% from a HP of 55 mV (N=5, n=8, Figure 2D and 2F). Such a sensitivity to isradipine further confirmed that the remaining ICa in SAN cells from CaV3.1/ mice was ICa,L.
|
Sedated CaV3.1/ Mice Have Intrinsic Slower Heart Rate and Prolonged AV Conduction
We next performed surface ECG recordings on sedated WT and CaV3.1/ mice (Figure 3). Because the heart rate is highly regulated by the balance between the sympathetic and vagal input, which depends on the levels of stress and anesthesia, ECGs were also recorded after injection of propranolol and atropine to block the autonomic nervous system (ANS).28 Recording examples collected from WT (+/+) and CaV3.1/ (/) mice before and after the ANS block are presented in Figure 3A. The loss of the CaV3.1 subunit induced a significant (9%) prolongation of the atrioventricular conduction (PQ interval) under baseline conditions (34±1 ms, N=11, and 37±1 ms, N=12 for WT and CaV3.1/ mice, respectively; P<0.05). The heart beat (RR interval), P wave duration, and QRS interval (Figure 3B), as well as the QTc interval (data not shown; 62±1 ms and 61±1 ms for WT and CaV3.1/ mice, respectively; P>0.05), were not significantly modified. In conditions of ANS block, the intrinsic heart rate was significantly slowed by &10%. Indeed, the RR interval was significantly longer in CaV3.1/ mice than in WT animals (144±2 ms and 132±2 ms, respectively; P<0.05; Figure 3B). The PQ interval was also markedly prolonged (34±1 ms and 40±1 ms in WT and CaV3.1/ animals, respectively; P<0.001; Figure 4B). The other ECG parameters were not significantly modified.
|
|
SAN Cells From CaV3.1/ Mice Display Slowed Pacemaker Activity
The spontaneous activity of isolated SAN cells was studied to evaluate whether the slowing of the intrinsic heart rate observed in vivo in CaV3.1/ mice was associated with dysfunction of SAN cell automaticity. Representative recordings obtained on WT and CaV3.1/ SAN cells are presented in Figure 4A (upper and lower traces, respectively). Analysis of these recordings showed that inactivation of cacna1g gene resulted in a 37% slowing of the cellular beating rate (163±13 bpm, N=4, n=15 in CaV3.1/, and 234±19 bpm, N=5, n=14 in SAN cells from WT mice; P<0.01; Figure 4B). Slowing of cellular pacemaking was accompanied by a reduction of the diastolic depolarization slope of &44% (Figure 4C). No significant changes in the maximum diastolic potential (MDP) and the voltage threshold of the action potential upstroke (Eth) were observed (MDP: 56.9±1.3 mV in WT, n=15, and 58.2±1.4 mV for CaV3.1/ SAN cells, n=14; Eth: 45±1.3 mV in WT and 43±1.4 mV in CaV3.1/ SAN cells; Figure 4D). Also, the action potential duration (147±15 and 141±10 ms for CaV3.1/ and WT SAN cells, respectively; Figure 4E) and the action potential amplitude (APA) (92±8 and 90±8 mV for CaV3.1/ and WT SAN cells, respectively; not shown) were comparable in SAN cells from WT and Cav3.1/ mice.
Intracardiac Electrophysiology Study of CaV3.1/ Mice
The AV conduction delay in mice lacking Cav3.1 channels was measured under baseline intracardiac recording conditions. Eight of 10 WT and 7 of 9 CaV3.1/ mice had a distinctly visible His-bundle electrogram (Figure 5A). In this group of animals, atrial-His (AH) conduction times were significantly longer in CaV3.1/ mice (31±1 ms) than in WT animals (25±1 ms; P<0.001; Figure 5B). However, His-ventricle (HV) intervals were comparable (11±1 and 10±1 ms for WT and CaV3.1/ mice, respectively; P>0.05). Effective refractory periods at the atrial (AERP), atrioventricular (AVERP), and ventricular (VERP) levels were investigated at a basic cycle length of 100 ms (Figure 5C). AERP and VERP were not significantly different between WT and Cav3.1/ mice. In contrast, the AVERP was significantly longer in CaV3.1/ mice (58±6 ms; N=8) than in WT animals (44±2 ms; N=10; P<0.05). Decremental atrial pacing revealed that Wenckebach cycle length was significantly longer in CaV3.1/ mice than in WT mice (85±5 ms and 67±2 ms, respectively; P<0.01; Figure 5C). Atrial pacing confirmed SAN dysfunction. Indeed, the corrected SAN recovery time (cSNRT) was longer in CaV3.1/ mice than in WT mice (31±5 in Cav3.1/ and 17±2 ms in WT mice P<0.05; n=7 and 9, respectively).
|
AVN Cells From CaV3.1/ Mice Lack ICa,T
We then tested whether dysfunction of AV conduction observed on inactivation of Cav3.1 channels was associated with downregulation of ICa,T in the AVN. ICa,T and ICa,L were recorded in isolated AVN cells using the same recording protocols as for SAN cells (Figure 6). ICa,T was found in all the WT AVN cells investigated (Figure 6A). Indeed, switching the HP from 90 to 60 mV significantly shifted the V0.5act of the total ICa from 34±0.7 to 23±0.8 mV (n=7, P<0.05). In contrast, no ICa,T could be recorded in Cav3.1/ AVN cells (Figure 6Ab), and switching the HP from 90 to 60 mV did not shift the V0.5act value (25±1.3 mV to 27±0.8 mV, respectively; P=NS; Figure 6Bb). The peak density of the residual ICa measured from a HP of 60 mV in AVN cells was not altered by inactivation of Cav3.1 channels (4.1±0.5 pA/pF, N=5, n=7 in WT and 4.6±0.7 pA/pF, N=4, n=7 in Cav3.1/; P=NS). In addition, no ICa,T could be detected in isolated cells from the RA of WT adult mice (Figure 6C and 6D), because switching the HP from 100 to 50 mV produced no change both in the V0.5act (16±2 and 17±1 mV, N=3, n=8, P=NS; Figure 6D) and in the peak density (6.9±1.5 and 7±1 pA/pF, N=3, n=8, P=NS; Figure 6C).
|
Bradycardia in Conscious Unrestrained CaV3.1/ Mice
Both the heart rate and the AV conduction were altered in freely moving CaV3.1/ mice (Figure 7A and 7B and the Table). The mean heart rate was significantly slowed in CaV3.1/ mice, when considering a 24-hour period or during the day and night periods (Figure 7B and the Table). The maximum cardiac frequency during short periods of activity (40 seconds) was unchanged (Table), suggesting that activation of other ionic channels involved in SAN automaticity can compensate for the lack of ICa,T during strong activation of the sympathetic nervous system. Spectral analysis of RR signals in the frequency domain revealed no differences between the 2 groups of mice. Total spectral power, ultralow (ULF), very-low (VLF), low (LF), and high (HF) frequencies were not significantly modified between WT and CaV3.1/ mice (Figure 7C, data not shown for ULF and VLF), indicating that the degree of autonomic regulation of heart rate was not altered in CaV3.1/ mice.
|
|
Telemetric recordings also confirmed the prolongation of the PQ interval in Cav3.1/ mice (Table), demonstrating that the propagation of the heartbeat through the AV conduction system was delayed in CaV3.1/ mice. This effect was independent from the heart rate because measurements were performed at comparable heart rates (600 bpm; cycle length of 100 ms). In contrast, the atrial conduction (as assessed by the P wave duration), the ventricular conduction (QRS interval), and ventricular repolarization (QT interval) were unchanged (Table). In addition, we did not find evidence for cardiac arrhythmias in CaV3.1/ mice. Also, no significant difference in the systolic, diastolic, and mean arterial pressure (60±8 mm Hg, N=8 in WT and 72±5 mm Hg, N=8 in Cav3.1/ mice; P=NS) was observed between the 2 mouse strains (Figure 7D).
| Discussion |
|---|
|
|
|---|
1G T-type Ca2+ channels in mice results in a significant slowing of the heart rate and AV conduction. Downregulation of ICa,T in both SAN and AVN cells of CaV3.1/ animals is documented, accounting for this in vivo phenotype. The lack of Cav3.1 channels in isolated SAN cells induces slowing of pacemaker activity through a reduction of the slope of the diastolic depolarization. Our study provides novel and compelling genetic evidence for a direct contribution of Cav3.1 channels in the setting of the mammalian cardiac impulse generation and propagation by contributing to both the diastolic depolarization in the SAN and impulse conduction through the AVN.
ICa,T in SAN and AVN Cells Following Inactivation of Cav3.1 Channels
A striking observation of this study is that ICa,T in the mouse SAN is predominantly generated by the CaV3.1 subunit because we found no evidence for a residual ICa,T in Cav3.1/ mice in both SAN (Figure 1) and AVN cells (Figure 6). The low sensitivity of SAN ICa,T to Ni2+ is consistent with that observed on recombinant Cav3.1-mediated ICa,T.27 Also consistent with our general findings is the recent observation that CaV3.2/ mice showed no ECG alterations.29 Inactivation of Cav3.1 channels did not significantly modify the expression of ICa,L in Cav3.1/ in both SAN and AVN cells. Our data show, therefore, that expression of CaV3.2, Cav1.3, and Cav1.2 subunits do not compensate for the lack of Cav3.1 channels in Cav3.1/ mice.
Bradycardia and Atrioventricular Dysfunction in Cav3.1/ Mice
ECGs and intracardiac recordings document both bradycardia and slowing of the atrioventricular conduction in CaV3.1/ mice. Several lines of evidence indicate that bradycardia is attributable to slowing of the pacemaker activity in the SAN. First, bradycardia was evident in sedated mice under pharmacological blockade of the ANS input for heart rates that were comparable with the mean heart rate observed in freely moving mice. Second, slowing of the heart rate was observed in freely moving mice in the absence of a significant change both in the heart rate variability profile and in the arterial blood pressure, thus arguing against the hypothesis that bradycardia would be caused by dysfunction in the autonomic regulation of the heart rate or could be secondary to a change in the control of the vascular tone. The prolongation of the SAN recovery time also indicates dysfunction in SAN automaticity. Finally, the slowing of pacemaker activity observed in isolated SAN pacemaker cells of Cav3.1/ mice is consistent with bradycardia being attributable to the lack of ICa,T in the SAN. The reduction of the mean heart rate measured on freely moving Cav3.1/ mice is moderate, compared with the slowing of the cycle length in isolated pacemaker cells (10% in freely moving mice and 37% in isolated cells). This difference can be caused by the compensatory adrenergic tone in vivo, which stimulates ionic mechanisms involved in pacemaking, such as Cav1.3-mediated ICa,L9,10 and If6 and RyR-dependent diastolic release of Ca2+.11 The observation that the maximal heart rate is comparable in WT and Cav3.1/ mice is consistent with this hypothesis. Comparison of mice lacking Cav1.39 and Cav3.1 channels (this study) indicate that ICa,L and ICa,T play distinct roles in pacemaker activity in vivo. Indeed, knockout of Cav1.3 channels reduces the basal and intrinsic heart rate in sedated conditions by approximately 20% and 60%, respectively,9 compared with the 10% reduction observed in mice lacking Cav3.1 channels in both freely moving and block of ANS conditions. These observations suggest that Cav3.1 channels contribute to the setting of the basal heart rate but have less impact on the dynamic regulation of pacemaker activity by the ANS. The lack of a significant change in the variability of the RR intervals in Cav3.1 mice is consistent with this hypothesis.
We report that the slowing of the AV conduction in Cav3.1/ mice is caused by dysfunction in the excitability of the AVN. Indeed, intracardiac recordings show a delay in the AH conduction time and AVERP, in the absence of a prolongation of the P wave, which indicates similar conduction velocities in atria from WT and Cav3.1/ mice. Consistently with ECGs and intracardiac recordings, we found no ICa,T in atrial myocytes from WT mice. Also, AVN cells display ICa,T related to CaV3.1 channels because it was no longer detectable in CaV3.1/ mice. We did not find significant changes in the HV, QRS, and QT intervals (see Figures 3 and 5
and supplemental Figure III), indicating that the lack of Cav3.1 channels does not affect conduction through the HisPurkinje fiber network or the ventricular muscle. This phenotype differs from that of SCN5A+/ mice,19 which shows prominent alteration of the P wave and the QRS complex duration,30 stressing the importance of the cardiac INa in intraatrial and HisPurkinje conduction. Also in contrast with SCN5A+/,19 Cav3.1/ mice do not present ventricular tachiarrhythmias. This SCN5A-mediated INa can possibly compensate for the lack of ICa,T in the HisPurkinje system.
Pacemaking in Cav3.1/ Mice
We describe that inactivation of CaV3.1 channels significantly prolongs the pacemaker cycle length in isolated SAN cells by reducing the slope of the diastolic depolarization, demonstrating the involvement of Cav3.1-mediated ICa,T in the setting of the diastolic depolarization in mouse SAN cells. In an attempt to compare the physiological roles of Cav3.1-mediated ICa,T with that of Cav1.3-mediated ICa,L and INa, we have developed a numerical model of mouse SAN electrophysiology based on previous studies on mouse SAN pacemaking in normal and genetically modified mouse strains (see supplemental Figures IV and V). Our numerical simulations indicate that Cav3.1 channels contribute to pacemaking by activating during the diastolic depolarization for more negative voltages than TTX-sensitive INa and Cav1.3-mediated ICa,L (see supplemental Figure VB and VE). As a consequence, Cav3.1 channels can accelerate the diastolic depolarization rate in a voltage range in which INa is still not activated. This property can explain, at least in part, how Cav3.1 channels can contribute to pacemaking in spite of their relatively low availability at SAN diastolic potentials. An expanded discussion about the development, the features and limitations of our numerical model, and the physiological significance of Cav3.1-mediated ICa,T compared with that of ICa,L and INa is available in the online data supplement.
Conclusion
In conclusion, our study demonstrates that CaV3.1 channels contribute to the heartbeat by influencing pacemaking and the AV conduction. To date, the presence of T-type channels in human heart is poorly documented. Molecular analyses, such as dot blots and Northern blots of human heart mRNAs, have identified transcripts for CaV3.1 and CaV3.2.31,32 T-type channels may play a role in the human SAN and the conduction system. For instance, the causality between congenital heart block induced by maternal autoantibodies against T-type channels and children showing SAN bradycardia and atrioventricular block has recently been documented.33 There is growing evidence that T-type channels may constitute a promising pharmacological target for the treatment of human diseases, such as epilepsy and chronic pain.34 From our observations, T-type channel inhibition would have no deleterious consequences in cardiac physiology. It is, therefore, tempting to speculate that selective blockers of CaV3.1 channels may hold promise for the therapeutic management of the cardiac diseases that require moderate heart rate reduction, such as cardiac ischemia and coronary heart disease.
| Acknowledgments |
|---|
| Footnotes |
|---|
Original received November 5, 2004; resubmission received December 5, 2005; revised resubmission received March 30, 2006; accepted April 27, 2006.
| References |
|---|
|
|
|---|
1D calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice. Circ Res. 2002; 90: 981987.
1G T-type Ca2+ channels. Neuron. 2001; 31: 3545.[CrossRef][Medline]
[Order article via Infotrieve]
1H T-type Ca2+ channels. Science. 2003; 302: 14161418.
1G subunit that forms T-type calcium channels. J Biol Chem. 2000; 275: 60906100.This article has been cited by other articles:
![]() |
K. C. Bittner and D. A. Hanck The Relationship between Single-Channel and Whole-Cell Conductance in the T-type Ca2+ Channel CaV3.1 Biophys. J., July 15, 2008; 95(2): 931 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Mangoni and J. Nargeot Genesis and Regulation of the Heart Automaticity Physiol Rev, July 1, 2008; 88(3): 919 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fukuzaki, T. Sato, T. Miki, S. Seino, and H. Nakaya Role of sarcolemmal ATP-sensitive K+ channels in the regulation of sinoatrial node automaticity: an evaluation using Kir6.2-deficient mice J. Physiol., June 1, 2008; 586(11): 2767 - 2778. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, V. Timofeyev, L. Lu, N. Li, A. Singapuri, M. K. Long, C. T. Bond, J. P. Adelman, and N. Chiamvimonvat Functional Roles of a Ca2+-Activated K+ Channel in Atrioventricular Nodes Circ. Res., February 29, 2008; 102(4): 465 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Thireau, B. L. Zhang, D. Poisson, and D. Babuty Heart rate variability in mice: a theoretical and practical guide Exp Physiol, January 1, 2008; 93(1): 83 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chemin, A. Mezghrani, I. Bidaud, S. Dupasquier, F. Marger, C. Barrere, J. Nargeot, and P. Lory Temperature-dependent Modulation of CaV3 T-type Calcium Channels by Protein Kinases C and A in Mammalian Cells J. Biol. Chem., November 9, 2007; 282(45): 32710 - 32718. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yanagi, M. Takano, G. Narazaki, H. Uosaki, T. Hoshino, T. Ishii, T. Misaki, and J. K. Yamashita Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels and T-Type Calcium Channels Confer Automaticity of Embryonic Stem Cell-Derived Cardiomyocytes Stem Cells, November 1, 2007; 25(11): 2712 - 2719. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Baruscotti and R. B. Robinson Electrophysiology and pacemaker function of the developing sinoatrial node Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2613 - H2623. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Navedo, G. C. Amberg, R. E. Westenbroek, M. J. Sinnegger-Brauns, W. A. Catterall, J. Striessnig, and L. F. Santana Cav1.3 channels produce persistent calcium sparklets, but Cav1.2 channels are responsible for sparklets in mouse arterial smooth muscle Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1359 - H1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M.H. Hoogaars, A. Engel, J. F. Brons, A. O. Verkerk, F. J. de Lange, L.Y. E. Wong, M. L. Bakker, D. E. Clout, V. Wakker, P. Barnett, et al. Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria Genes & Dev., May 1, 2007; 21(9): 1098 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dobrzynski, M. R. Boyett, and R. H. Anderson New Insights Into Pacemaker Activity: Promoting Understanding of Sick Sinus Syndrome Circulation, April 10, 2007; 115(14): 1921 - 1932. [Full Text] [PDF] |
||||
![]() |
J. Chemin, J. Nargeot, and P. Lory Chemical Determinants Involved in Anandamide-induced Inhibition of T-type Calcium Channels J. Biol. Chem., January 26, 2007; 282(4): 2314 - 2323. |